From: Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review
Prebiotic studies | Location | Inclusion criteria | Treatment used in study groups, n = | Treatment duration | Reported outcomes |
---|---|---|---|---|---|
Bettler 200637 | USA | <14 days postnatal age, birth weight and current weight between 10–90 percentiles for age | 1) Prebiotic group: FOS 1.5 g/L n=72 | 12 weeks | Growth: Weight, length, Head circumference |
 |  |  | 2) Prebiotic group: FOS 3.0 g/L n= 74 |  |  |
 |  |  | 3) Placebo group: Conventional infant formula no prebiotic, n=66 |  |  |
Bruzzese 200939 | Milan, Napoli, Verona Italy | 37 to 42 weeks gestation, > 2500g birth weight, 4 to 6 months old | 1) Prebiotic group: GOS, FOS (ratio 9:1) 0.4 g/100 ml n= 96 | 12 months | Growth, Weight, length. Stool consistency |
 |  |  | 2) Placebo group: conventional formula with no prebiotic, N= 105 |  | Infections: diarrhea episodes / child 12 months, episodes of acute diarrhea, episodes of URTI, antibiotic use |
Costalos 200841 | Greece | Birth weight between 10th and 90th percentiles, no breastfeeding after age of 14 days | 1) Prebiotic group: 90% G0S 10% LcFOS 0.4 g/100 ml n=70 | 6 weeks | Growth: Weight gain, length and head circumference gain |
 |  |  | 2) Placebo group: Conventional formula no prebiotic n=−70 |  | Stool frequency, consistency. GI Microflora: Bifidobacteria, E coli |
Fanaro 200542 | Ferrara, Italy | Healthy full term infants, without antibiotic treatment | 1) Prebiotic group: Acidic Oligosaccharides 0.2 g/dl, Maltodextrin 0.2 g/dl n= 16 | 6 weeks | Growth: Weight and length gain. Stool consistency |
 |  |  | 2) Prebiotic group: Acidic Oligosaccharides 0.2 g/dl, Neutral GOS FOS 0.6 g/dl n= 15 |  | Crying, regurgitation and vomiting episodes |
 |  |  | 3) Placebo group: Maltodextrin at 8g/dl n=15 |  | Gi Microflora |
Fanaro 200843 | Ferrara, Turin Italy, Las Palmas, Seville Spain | Appropriate for gestational age, birth weight > 1500g, 4 to 6 months old | 1) Prebiotic group: GOS 5 g/L n= 56 | 18 weeks | Growth: Weight, length |
 |  |  |  |  | Stool frequency, consistency |
 |  |  |  |  | GI microflora: Bifidobacteria, Lactobacilli, Bacteriodes, |
 |  |  |  |  | Clostridia, Enterobacteriacae |
Moro 200235 (Moro 2003, considered as one study) | Milan Italy | 39 to 40 weeks gestational age | 1) Prebiotic group: GOS, FOS 0.4 g/dl n=30 | 28 days | Growth: Weight and length gain |
 |  |  | 2) Prebiotic group: GOS FOS 0.8 g/dl n= 27 |  | Stool frequency, consistency |
 |  |  | 3) Placebo group: Maltodextrin at 0.8g/dl n=33 |  | Crying, regurgitation and vomiting |
 |  |  | 4) Reference group: Breast milk n=15 |  | Feeding volume |
 |  |  |  |  | GI microflora: Bifidobaceria, Lactobacilli |
Moro 200547 | Italy | Healthy full term infants, appropriate for gestational age | 1) Prebiotic group: GOS 0.8g/dl, n= 16 | 28 days | Growth: Weight, length gain |
 |  |  | 2) Placebo group: Maltodextrin at 0. 8g/dl n=16 |  | Feeding volume |
 |  |  |  |  | GI microflora |
Moro 200637 (Arslanoglu 2007, Arslanoglu 2008 considered as one study) | Milan Italy | 37 - 42 weeks gestational age | 1) Prebiotic group: ScGOS Lc FOS at 8g/L, n= 104 | 6 months | Growth: Weight gain, length gain, head circumference |
 |  |  | 2) Placebo group: Maltodextrin at 8g/L, n=102 |  | Stool frequency, consistency |
 |  |  |  |  | Crying, regurgitation and vomiting |
 |  |  |  |  | GI microflora: Bifidobacteria, Lactobacilli |
 |  |  |  |  | Infectious episodes: Overall infections, URTI, Otis Media, GI infections, UTI, antibiotic use |
Schmelzle 200349 | Griefswald Germany | 37 to 42 weeks gestational age, birth weight between 10 to 90 percentiles, exclusive formula feeding by age 14 days old | 1) Prebiotic group: 90% GOS, 10% FOS 0.8/100ml n=76 | 12 weeks | Growth: Males - Weight gain, length gain, head circumference |
 |  |  | 2) Placebo group: Conventional infant formula, no prebiotic, n=78 |  | Females - Growth: Weight gain, length gain, head circumference |
 |  |  |  |  | Volume of feed (formula) |
 |  |  |  |  | GI microflora: Bifidobacteria |
Xiao-Ming 200453 | Nanjing China | Healthy full term infants | 1) Prebiotic group: Galactooligosaccharide 0.24 g/ dl n=69 | 6 months | GI Microflora: Bifidobacteria, Lactobacilli, E coli |
 |  |  | 2) Prebiotic formula with Human milk n= 124 |  |  |
 |  |  | 3) Placebo group: Conventional infant formula, no prebiotic, n=52 |  |  |
 |  |  | 4) Reference group: Human milk n= 26 |  |  |
Xiao-Ming 200854 | Nanjing China | > 38 weeks gestation, Birth weight > 3kg | 1) Prebiotic group 1: Galactooligosaccharide 0.24 g/ 100 ml n=37 | 3 months | Growth: Weight gain, length gain |
 |  |  |  |  | Stool consistency |
 |  |  | 2) Prebiotic group 2: Prebiotic formula with Human milk n= 58 |  | Crying, regurgitation and vomiting scores |
 |  |  |  |  | Volume of feed |
 |  |  | 3) Placebo group: Conventional infant formula, no prebiotic, n=45 |  | GI Microflora: Bifidobacteria, Lactobacilli, E coli |
 |  |  | 4) Reference group: Human milk n= 24 |  |  |
Ziegler 200756 | USA | > 37 weeks gestation, Birth weight 2500g, solely formula fed | 1) Prebiotic group 1: Polydextrose, Galactooligosaccharide n=58 | 120 days | Growth: Weight gain, length gain, head circumference |
 |  |  |  |  | Stool frequency, consistency |
 |  |  | 2) Prebiotic group 2: Polydextrose, Galactooligosaccharide, Lactulose n= 48 |  | Intolerance to formula: Vomiting, diarrhea, excessive spitting, colic |
 |  |  | 3) Placebo group: Conventional infant formula, no prebiotic, n=58 |  |  |